Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

High Levels of Methylarginines Were Associated with Increased Mortality in Patients with Severe Sepsis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Acute Lung Injury in Critically Ill Patients: Actin-Scavenger Gelsolin Signals Prolonged Respiratory Failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Absences of Endothelial Microvesicle Changes in the Presence of the Endotheliopathy of Trauma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Lactate is a Prognostic Factor in Patients Admitted with Suspected ST-Elevation Myocardial Infarction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Transfusion Strategies are Associated with Epigenetic Changes Following Blunt Trauma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

INTRODUCTION: Nitric oxide (NO) likely plays a pivotal role in the pathogenesis of sepsis. Arginine is a substrate for NO, whereas the methylated arginines - asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) - are endogenous byproducts of proteolysis that inhibit NO production.We investigated if high plasma levels of ADMA, SDMA and arginine/ADMA ratio were associated with 90-day mortality in patients with severe sepsis or septic shock.

METHODS: We included 267 adult patients admitted to intensive care unit with severe sepsis or septic shock. The patients had previously been included in the randomized controlled trial "Scandinavian Starch for Severe Sepsis and Septic Shock (6S)". ADMA, SDMA and arginine/ADMA ratio were measured in plasma. The risk of death within 90 days were estimated in multivariate Cox regression analyses adjusted for gender, age ≥ 65 years, major cardiovascular disease, diabetes, hypertension, respiratory failure, vasopressor treatment, highest quartile of creatinine and bilirubin, and lowest quartile of platelet count. In the regression analyses missing values were estimated using multiple imputation.

RESULTS: Twenty-five patients had missing data in one or more of the baseline variables and 44 patients had missing methylarginine values. Both ADMA and SDMA were independently associated with 90-day mortality (ADMA: hazard ratio 1.54; 95% CI, 1.00-2.38; p = 0.046, and SDMA: hazard ratio 1.78; 95% CI, 1.14-2.72; p = 0.011). Arginine/ADMA ratio was not associated with 90-day mortality neither in univariate nor multivariate analyses. The difference in mortality between patients with high and low ADMA was most pronounced in the first week after inclusion.

CONCLUSIONS: High levels of ADMA and SDMA in plasma were associated with increased 90-day mortality in patients with severe sepsis or septic shock. Interfering with the methylarginine-NO systems may be a novel target in these patients.

OriginalsprogEngelsk
TidsskriftShock
Vol/bind46
Udgave nummer4
Sider (fra-til)365-72
ISSN1073-2322
DOI
StatusUdgivet - 2016

ID: 46456164